Braskem S.A. (BAK) vs Brenntag SE (BNR.DE)
The same free fields, in the same order, for both companies, so a figure on one line can be read straight across.
This page states measurements and nothing else. It does not rank the two companies, name one of them, or draw a conclusion from the figures.
Data as of Oct 27, 2026, for both companies.
The figures, field by field
A dash means the snapshot carries no figure for that company on that line. A line is dropped only when neither company has it, so a dash beside a figure is a fact about coverage, not about either company.
| BAK | BNR.DE | |
|---|---|---|
| Sector | Basic Materials | Basic Materials |
| Industry | Chemicals | Specialty Chemicals |
| Size band | SMALL | MID |
| Listing | NYSE | XETRA |
| Country | Brazil | Germany |
| Theme | commodity-chemicals | specialty-chemicals |
| Price and returns | ||
| Last close | $1.10 | 64.48 EUR |
| Return · 1 week | −35.29% | +1.70% |
| Return · 1 month | −26.17% | +8.77% |
| Return · 3 months | −53.59% | +9.10% |
| Return · year to date | −62.33% | +34.37% |
| Return · 1 year | −59.56% | +32.42% |
| Distance from the 52-week highThe last close measured against the highest close of the past 52 weeks. | −79.61% | −3.56% |
| 52-week high | $5.40 | 66.86 EUR |
| 52-week low | $0.93 | 43.72 EUR |
| Size and turnover | ||
| Market value · USDConverted to US dollars, so two companies listed in different currencies sit under one heading. | $248.55M | $9.92B |
| Turnover · median day, USDThe median value traded in a session over the past 50 sessions. | $1.79M | $13.88M |
| Employees | 8,233 | 16,942 |
| Valuation | ||
| Price to earnings · trailing | n/a (negative earnings) | 23.95× |
| Price to earnings · forward | n/a (negative forward earnings) | 14.47× |
| Price to sales | 0.01× | 0.58× |
| Price to book | n/a (negative book value) | 1.97× |
| Enterprise value to EBITDA | 7.50× | 11.17× |
| Enterprise value to revenue | 0.89× | 0.77× |
| PEG ratio | n/a (negative earnings) | 1.14 |
| Earnings per share · trailing | -2.60 | 2.52 |
| Profitability | ||
| Gross margin | 8.92% | 25.96% |
| Operating margin | 17.35% | 7.16% |
| Profit margin | −7.85% | 2.41% |
| Return on equity | — | 8.53% |
| Return on assets | 3.46% | 4.96% |
| Growth | ||
| Revenue growth | +21.60% | +10.20% |
| Earnings growth | — | +321.70% |
| Balance sheet and payout | ||
| Debt / equity (%) | — | 80.70 |
| Current ratio | 0.77 | 1.70 |
| Dividend yield | 0.00% | 3.20% |
| Payout ratio | 297.03% | 75.40% |
| Trend and volatility | ||
| RSI · 14 | 27.63 | 66.85 |
| ADX · 14 | 17.99 | 22.99 |
| 50-day average | $1.75 | 61.12 EUR |
| 200-day average | $3.07 | 57.08 EUR |
| Average true range · share of priceAverage true range over 14 sessions, stated as a share of the last close, so it can be read across two share prices. | 16.24% | 1.81% |
The full BAK analysis
Everything this table leaves out for Braskem S.A.: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the BAK argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full BAK analysisThe full BNR.DE analysis
Everything this table leaves out for Brenntag SE: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the BNR.DE argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full BNR.DE analysis